Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Micrologix Biotech initiates phase I trial in U.S. with MBI-226

Dec. 10, 1998

LY-303366: therapeutic and prophylactic efficacy in pulmonary aspergillosis in neutropenic animals

Dec. 9, 1998

Water-soluble antifungal agents enter the pipeline at Takeda

Dec. 8, 1998

Japanese lab prepares new, broad-spectrum carbapenems

Dec. 7, 1998

Potent antifungal triazoles reported by Sankyo

Dec. 7, 1998

Potent anti-MRSA agents developed by Sankyo

Dec. 4, 1998

Ascent to terminate copromotion agreement with Bristol-Myers Squibb

Dec. 4, 1998

Ascent to promote Warner-Lambert's Omnicef

Dec. 3, 1998

Bausch & Lomb to manufacture Lidakol for treatment of oral-facial herpes

Dec. 3, 1998

AMBI seeks partners to develop injectable nisin for treatment of hospital-acquired infections

Dec. 3, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...